162 related articles for article (PubMed ID: 16314732)
1. Interferon-gamma, but not interferon-alpha, induces SOCS 3 expression in human melanoma cell lines.
Kovarik A; Fojtova M; Boudny V; Adamkova L; Lauerova L; Kovarik J
Melanoma Res; 2005 Dec; 15(6):481-8. PubMed ID: 16314732
[TBL] [Abstract][Full Text] [Related]
2. Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells.
Fojtova M; Boudny V; Kovarik A; Lauerova L; Adamkova L; Souckova K; Jarkovsky J; Kovarik J
Br J Cancer; 2007 Jul; 97(2):231-7. PubMed ID: 17579625
[TBL] [Abstract][Full Text] [Related]
3. Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.
Lesinski GB; Zimmerer JM; Kreiner M; Trefry J; Bill MA; Young GS; Becknell B; Carson WE
BMC Cancer; 2010 Apr; 10():142. PubMed ID: 20398276
[TBL] [Abstract][Full Text] [Related]
4. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
[TBL] [Abstract][Full Text] [Related]
6. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression.
Pauli EK; Schmolke M; Wolff T; Viemann D; Roth J; Bode JG; Ludwig S
PLoS Pathog; 2008 Nov; 4(11):e1000196. PubMed ID: 18989459
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium bovis bacillus Calmette-Guérin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages.
Imai K; Kurita-Ochiai T; Ochiai K
FEMS Immunol Med Microbiol; 2003 Nov; 39(2):173-80. PubMed ID: 14625101
[TBL] [Abstract][Full Text] [Related]
8. Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation.
Kovarik J; Boudny V; Kocak I; Lauerova L; Fait V; Vagundova M
Int J Mol Med; 2003 Sep; 12(3):335-40. PubMed ID: 12883649
[TBL] [Abstract][Full Text] [Related]
9. Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts.
Ramana CV; Kumar A; Enelow R
Biochem Biophys Res Commun; 2005 Feb; 327(3):727-33. PubMed ID: 15649407
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.
Karlsen AE; Rønn SG; Lindberg K; Johannesen J; Galsgaard ED; Pociot F; Nielsen JH; Mandrup-Poulsen T; Nerup J; Billestrup N
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12191-6. PubMed ID: 11593036
[TBL] [Abstract][Full Text] [Related]
12. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
13. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).
Chawla-Sarkar M; Leaman DW; Jacobs BS; Tuthill RJ; Chatterjee-Kishore M; Stark GR; Borden EC
J Interferon Cytokine Res; 2002 May; 22(5):603-13. PubMed ID: 12060499
[TBL] [Abstract][Full Text] [Related]
14. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions.
Mazzarella G; MacDonald TT; Salvati VM; Mulligan P; Pasquale L; Stefanile R; Lionetti P; Auricchio S; Pallone F; Troncone R; Monteleone G
Am J Pathol; 2003 Jun; 162(6):1845-55. PubMed ID: 12759242
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
[TBL] [Abstract][Full Text] [Related]
17. Cross-inhibition of interferon-induced signals by GM-CSF through a block in Stat1 activation.
Kasper S; Kindler T; Sonnenschein S; Breitenbuecher F; Böhmer FD; Huber C; Fischer T
J Interferon Cytokine Res; 2007 Nov; 27(11):947-59. PubMed ID: 18052729
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs.
Wong LH; Hatzinisiriou I; Devenish RJ; Ralph SJ
J Immunol; 1998 Jun; 160(11):5475-84. PubMed ID: 9605150
[TBL] [Abstract][Full Text] [Related]
19. Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling.
Skjesol A; Liebe T; Iliev DB; Thomassen EI; Tollersrud LG; Sobhkhez M; Lindenskov Joensen L; Secombes CJ; Jørgensen JB
Dev Comp Immunol; 2014 Jul; 45(1):177-89. PubMed ID: 24582990
[TBL] [Abstract][Full Text] [Related]
20. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]